Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis



Rating:

Share or cite this content

Citations should be made in the following way:
R. Lazor, M. Reynaud-Gaubert, V. Cottin, J. Lacronique, C. Taillé, B. Wallaert, S. Hirschi, B. Crestani, J.F. Cordier, the Groupe d Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (Lausanne, Switzerland; Marseille, Lyon, Paris, Lille, Strasbourg, France). Rate of FEV1 decline in lymphangioleiomyomatosis associated with tuberous sclerosis complex. Eur Respir J 2012; 40: Suppl. 56, 683

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary function tests for lymphangioleiomyomatosis screening in women with tuberous sclerosis complex Source: International Congress 2016 – Orphan diseases I Year: 2016 Natural history of incidental sporadic or tuberous sclerosis complex associated lymphangioleiomyomatosis Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019 Severity and outcome of cystic lung disease in women with tuberous sclerosis complex Source: Eur Respir J 2015; 45: 171-180 Year: 2015 Alk-rearranged adenocarcinoma arising in lung lymphangioleiomyomatosis of a patient with tuberous sclerosis complex Source: International Congress 2019 – Lung cancer? Year: 2019 Hemoptysis: rare pulmonary manifestation of tuberous sclerosis in childhood Source: Eur Respir J 2006; 28: Suppl. 50, 544s Year: 2006 Pulmonary function in progressive systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Lymphangioleiomyomatosis Source: Eur Respir J 2006; 27: 1056-1065 Year: 2006 Pulmonary functions in systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019 Tuberous sclerosis complex (TSC) with pulmonary involvement - a retrospective review of 4 cases Source: Eur Respir J 2002; 20: Suppl. 38, 448s Year: 2002 Lymphangioleiomyomatosis: what do we know and what are we looking for? Source: Eur Respir Rev 2011; 20: 34-44 Year: 2011 Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation Source: ERJ Open Res, 5 (3) 00044-2019; 10.1183/23120541.00044-2019 Year: 2019 Relationship between FVC and respiratory muscle strength in patients with amyotrophic Lateral sclerosis (ALS) Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012 Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis Source: Eur Respir J 2008; 31: 678-680 Year: 2008 Pulmonary function in patients with sporadic lymphangioleiomyomatosis. Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021 Amyotrophic lateral sclerosis: predictors of respiratory impairment at disease diagnosis Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions Year: 2019 Association of FVC/DLCO with pulmonary hypertension risk and interstitial disease in systemic sclerosis patients Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Three cases of idiopathic pleuroparenchymal fibroelastosis associated with amyotrophic lateral sclerosis Source: International Congress 2014 – ILDs 4 Year: 2014 Pulmonary hypertension in systemic sclerosis: different phenotypes Source: Eur Respir Rev, 26 (145) 170056; 10.1183/16000617.0056-2017 Year: 2017